Announcements Trials
Browse Landscape

Phase

Phase 2 19Phase 3 6Phase 1 5Phase 1/2 3Phase NA 1

Status

Completed 3Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

INDUSTRY 4OTHER 2

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 6

Conditions

Prostatic Neoplasms 6Metastatic Castration-resistant Prostate Cancer (mCRPC) 1Metastatic Castration-resistant Prostate Cancer 1Hormone Refractory Prostate Cancer 1

Interventions

Prednisone 54Radiotherapy 52Docetaxel 51Leuprolide 48Goserelin 47bicalutamide 45enzalutamide 30acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 27Androgen Antagonists 27Flutamide 24Triptorelin Pamoate 22apalutamide 19Gonadotropin-Releasing Hormone 18Abiraterone Acetate 18abiraterone 16Radiation 15Zoledronic Acid 14Magnetic Resonance Spectroscopy 13gallium 68 PSMA-11 12Prednisolone 11luprolide acetate gel depot 10darolutamide 10cabazitaxel 9Radiosurgery 9Standard of Care 8Specimen Handling 8Radiotherapy, Intensity-Modulated 8Radiotherapy, Conformal 8Estramustine 8Dexamethasone 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × Prostatic Neoplasms × radium Ra 223 dichloride × Clear all
NCT07611110 2026-05-28

VECTRA-01

AstraZeneca

Phase 3 Recruiting
670 enrolled
Genitourinary

Prostatic Neoplasms

NCT02043678 2025-02-19

ERA 223

Bayer

Phase 3 Completed
806 enrolled 32 charts
Genitourinary

Prostatic Neoplasms

NCT05771896 2023-09-14

CARE

GenesisCare USA

Phase 3 Withdrawn
Genitourinary

Prostatic Neoplasms

NCT03458559 2020-11-17

RaRe

Amsterdam UMC, location VUmc

Phase 3 Unknown
402 enrolled
Genitourinary

Prostatic Neoplasms

NCT01810770 2018-09-19

Radium-223 Dichloride Asian Population Study in the Treatment of CRPC Patients With Bone Metastasis

Bayer

Phase 3 Completed
243 enrolled
Genitourinary

Prostatic Neoplasms

NCT01618370 2017-03-31

Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases

Bayer

Phase 3 Completed
705 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡